EXPLAINER: Final steps in US review of COVID-19 vaccine
Associated PressWASHINGTON — Pfizer’s COVID-19 vaccine is entering the final phase of review before the U.S. government decides whether to allow millions to get the shots. A look at the process: FDA REVIEW The agency’s scientific review is a key step — not just for the U.S. — but for countries around the world weighing whether to begin using a vaccine. FDA Commissioner Stephen Hahn says that careful approach carries weight far beyond the U.S. “The FDA is known around the world for its rigorous standards for safety and efficacy,” Hahn told The Associated Press. “I think you’ll see with the data we’re going to provide at the meeting that we have done our job.” VACCINE EXPERT MEETING Next, a group of about two dozen outside experts weighs in on the FDA’s findings and gives their own assessment.